Cargando…
Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma
Glioblastoma (GBM), the most malignant tumor of the central nervous system, is marked by its dynamic response to microenvironmental niches. In particular, this cellular plasticity contributes to the development of an immediate resistance during tumor treatment. Novel insights into the developmental...
Autores principales: | Maier, Julian P., Ravi, Vidhya M., Kueckelhaus, Jan, Behringer, Simon P., Garrelfs, Niklas, Will, Paulina, Sun, Na, von Ehr, Jasmin, Goeldner, Jonathan M., Pfeifer, Dietmar, Follo, Marie, Hannibal, Luciana, Walch, Axel Karl, Hofmann, Ulrich G., Beck, Jürgen, Heiland, Dieter Henrik, Schnell, Oliver, Joseph, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295384/ https://www.ncbi.nlm.nih.gov/pubmed/34290229 http://dx.doi.org/10.1038/s41419-021-03937-9 |
Ejemplares similares
-
Astrogliosis Releases Pro-Oncogenic Chitinase 3-Like 1 Causing MAPK Signaling in Glioblastoma
por: Wurm, Julian, et al.
Publicado: (2019) -
Metabotropic glutamate receptors inhibit microglial glutamate release
por: McMullan, Stephen M, et al.
Publicado: (2012) -
Optical Control of Metabotropic Glutamate Receptors
por: Levitz, Joshua, et al.
Publicado: (2013) -
Kinetic fingerprinting of metabotropic glutamate receptors
por: Kukaj, Taulant, et al.
Publicado: (2023) -
Human organotypic brain slice culture: a novel framework for environmental research in neuro-oncology
por: Ravi, Vidhya M, et al.
Publicado: (2019)